SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Mar-14 6:17 PM View: | Tranzyme, Inc. (OCRX) | 18-Mar-14 | Disposition (other) | 410,022 | -- | -- | (33%) 1.24M to 832.47K | |
17-Jul-13 5:47 PM View: | Tranzyme, Inc. (OCRX) | 15-Jul-13 | Purchase | 391,166 | $6.03 | $2,357,320.00 | (104%) (-377.19K) to 13.98K | |
03-Jan-12 8:31 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 30-Dec-11 | Market Sale | 25,000 | $6.22 | $155,625.00 | (< 1%) 4.02M to 4.0M | 100% |
23-Dec-11 6:22 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 22-Dec-11 | Market Sale | 25,000 | $6.22 | $155,605.00 | (< 1%) 4.05M to 4.02M | 100% |
23-Dec-11 6:22 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 21-Dec-11 | Market Sale | 25,000 | $6.51 | $162,770.00 | (< 1%) 4.07M to 4.05M | 100% |
08-Mar-10 9:45 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 04-Mar-10 | Grant | 1,164,660 | $6.73 | $7,839,950.00 | 100% 0 to 1.16M | (100%) |
08-Mar-10 9:45 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 04-Mar-10 | Conversion | 2,818,570 | $1.45 | $4,097,700.00 | 242% 1.16M to 3.98M | |
03-May-07 5:52 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 01-May-07 | Conversion | 2,822,850 | -- | -- | 100% 0 to 2.82M |